Bruker Daltonik GmbHDownload PDFPatent Trials and Appeals BoardJul 23, 20202019006006 (P.T.A.B. Jul. 23, 2020) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 14/419,010 02/02/2015 Jochen Franzen P3552US00 5696 110047 7590 07/23/2020 BENOIT & COTE 560 boul. Cremazie est Suite 300 Montreal, QUEBEC H2P 1E8 CANADA EXAMINER DEJONG, ERIC S ART UNIT PAPER NUMBER 1631 NOTIFICATION DATE DELIVERY MODE 07/23/2020 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): docket@benoit-cote.com phil@benoit-cote.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte JOCHEN FRANZEN, STEFAN KLEPEL, MARKUS KOSTRZEWA, and THOMAS MAIER1 Appeal 2019-006006 Application 14/419,010 Technology Center 1600 Before ERIC B. GRIMES, TAWEN CHANG, and RACHEL H. TOWNSEND Administrative Patent Judges. GRIMES, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134(a) involving claims to methods of recognizing microbe mixtures using mass spectrometry, which have been rejected as ineligible for patenting. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. 1 Appellant identifies the real party in interest as Bruker Daltonik GmbH. Appeal Brief filed Jan. 3, 2019 (“Appeal Br.”) 1. We use the word Appellant to refer to “applicant” as defined in 37 C.F.R. § 1.42(a). Appeal 2019-006006 Application 14/419,010 2 STATEMENT OF THE CASE “The routine, fast and error-free identification of many samples of microorganisms plays an important role particularly in clinical and extra- clinical infection diagnostics” and other fields. Spec. ¶ 2. “The identification of bacteria by mass-spectrometric measurements has been described in detail” in the prior art. Id. ¶ 8. “The identification is achieved by means of a similarity analysis between a mass spectrum of the bacteria to be identified and reference mass spectra (simply called reference spectra in the following) of known bacteria.” Id. A “score list [is created] with the names of the microbe strains whose reference spectra resulted in the best similarity scores.” Id. ¶ 21. “A mixture can be suspected when there are reference spectra in the first 20 or 30 best hits of the score list which belong to at least two different microbe species.” Id. ¶ 25. A “specialist must . . . assess whether the sample is a mixture of different microbe species when several microbe species are listed in the score list.” Id. ¶ 21. “Methods are increasingly being demanded which run automatically as far as possible, but nevertheless have a high identification certainty also when microbe mixtures are present.” Id. ¶ 22. “The invention thus proposes methods which allow an automatic evaluation program for the score lists to recognize the presence of a microbe mixture with a relatively high degree of certainty.” Id. ¶ 50. In one embodiment (represented by Appellant’s claim 1), “an experienced specialist determine[s] the relationships between the microbes of all the reference spectra in the library once, and add[s] to the library a matrix-like relationship list . . . called an ‘exclusion list.’” Id. ¶ 32. “With the aid of this list, [a] computer program for the evaluation of the mass spectra can then determine Appeal 2019-006006 Application 14/419,010 3 whether such a near relationship exists, and negate the presence of a mixture when this is the case.” Id. A second embodiment (represented by Appellant’s claim 2) “is based on the finding that what matters is not the taxonomically determined relationship between the microbes, but only the degree of similarity between their reference spectra.” Id. ¶ 34. This embodiment “therefore proposes to investigate the reference spectra of the different microbe species in the score list in respect of their mutual similarity, for example by means of the evaluation program for assessing the score list itself.” Id. ¶ 35. “If they are very similar, . . . no mixture is present. If, on the other hand, the reference spectra of the different microbe species are not similar to each other, this indicates to the user that the sample must be a mixture.” Id. Claims 1, 2, 6–8, and 10–13 are on appeal. Claims 1 and 2, reproduced below, are illustrative: 1. Method for the recognition of microbe mixtures and the mass-spectrometric identification of a microbe sample, comprising the steps of: providing a library of reference spectra of microbes and an exclusion list indicative of a degree of taxonomical relationship between the microbes of the reference spectra; acquiring a sample spectrum of the microbe sample; comparing the sample spectrum to the reference spectra in the library and compiling a similarity score list of the reference spectra that are most similar to the sample spectrum based on a known similarity indicator; determining, with the aid of the exclusion list, the taxonomical relationship between two microbes, whose reference spectra are present in the score list and which belong to different species; Appeal 2019-006006 Application 14/419,010 4 identifying the microbe sample as a microbe mixture if the determined taxonomical relationship is below a specified degree; and when a microbe mixture has been identified, performing a mixture analysis using combination spectra. 2. Method for the recognition of microbe mixtures and the mass-spectrometric identification of a microbe sample, comprising the steps of: providing a library of reference spectra of microbes; acquiring a sample spectrum of the microbe sample; comparing the sample spectrum to the reference spectra and compiling a similarity score list of reference spectra that are most similar to the sample spectrum based on a known similarity indicator; comparing two reference spectra of the score list whose microbes belong to different species to determine a degree of similarity between said two reference spectra; identifying the microbe sample as a microbe mixture if the similarity of said two compared reference spectra is below a predetermined similarity threshold; and when a microbe mixture has been identified, performing a mixture analysis using combination spectra. OPINION Claims 1, 2, 6–8, and 10–13 stand rejected under 35 U.S.C. § 101 “because the claimed invention is directed to a judicial exception (i.e., a law of nature, a natural phenomenon, or an abstract idea) without including additional elements that are sufficient to amount to significantly more than the judicial exception itself.” Ans. 3. The Examiner finds that “the claimed invention only involves the abstract consideration of data, per se.” Id. at 4. “[T]he purpose of the claims remains directed to an abstract, mathematical Appeal 2019-006006 Application 14/419,010 5 and algorithmic analysis of mass spectroscopic data for a specific purpose of identifying the particular microbe content of a given sample.” Id. The Examiner finds that “[n]o samples are modified by practicing the claim[ed] analysis nor are any new physical investigative techniques developed or applied to a microbe sample. The instant claims are not directed to a practical application of the judicial exception.” Id. The Examiner finds that the “final step of performing a mixture analysis using a combination spectra . . . only provide[s] additional extra-solution activities where combination spectra analysis may be performed.” Id. at 5. That is, the claimed analysis of mass spectroscopic data only distill[s] out new information pertaining to the comprehension of the pertinence of a microbe mixture. Following [which], a practitioner of the claimed invention is instructed to perform additional analysis. Such results . . . in new information being comprehended in the mind of said practitioner. As such, the instant claims lack[] any practical application in the realms of physical things and acts. Id. at 9. Appellant argues that, “in place of a specific analysis of the claim limitations, the examiner has provided highly generalized, and often inaccurate, statements intended to support the conclusion that the claims are directed to an abstract idea.” Appeal Br. 5. Appellant argues that the Examiner “also fails to identify the specific claim limitations that are believed to relate to this interpretation. Generalized statements like those mentioned above do not permit the applicant to properly understand the basis of the rejection.” Id. at 6. Appellant also argues that “[e]ach of independent Claims 1 and 2 provide a narrow improvement in one limited aspect of the mass- spectrometric identification of a microbe sample (the determination of Appeal 2019-006006 Application 14/419,010 6 whether or not to employ a mixture analysis using combination spectra).” Appeal Br. 7. Specifically: [P]rior art methods often left it unclear as to whether a species mixture was present that would have benefited from the use of a mixture analysis using combination spectra. The applicant’s method, however, does not rely solely on a similarity analysis but, rather, uses the degree of taxonomical relationship between microbes of different species in a score list as a means for determining quickly whether such a mixture analysis would likely be advantageous. This provides a significant technical improvement over prior art methods. Id. at 8. Thus, Appellant argues, the claimed method “provides a more accurate method of identifying when a sample contains a mix of microbe species so that a decision may be made as to whether a ‘mixture analysis using combination spectra’ should be employed.” Id. Appellant argues that “the McRO court was faced with a situation analogous to that of the present application.” Id. at 10, citing McRO, Inc. v. Bandai Namco Games Am. Inc., 837 F.3d 1299 (Fed. Cir. 2016). Appellant argues that “[t]he McRO court recognized that the claims in question were not ‘abstract ideas’ since they used limited rules in a process specifically designed to achieve an improved technological result in conventional industry practice.” Id. at 12. Appellant argues that “[t]he same analysis applies equally to the claims of the present invention, which also use limited rules to achieve an improved technological result in a specific field.” Id. Appellant also argues that “the examiner has not identified the parts of the rejected claims that are considered to be ‘extra-solution activities.’ . . . Moreover, there has been no evidence provided to support the contention that part or all of the claims represent ‘extra-solution activities.’” Appeal Br. 6–7. Appeal 2019-006006 Application 14/419,010 7 Principles of Law A. Section 101 An invention is patent-eligible if it claims a “new and useful process, machine, manufacture, or composition of matter.” 35 U.S.C. § 101. However, the U.S. Supreme Court has long interpreted 35 U.S.C. § 101 to include implicit exceptions: “[l]aws of nature, natural phenomena, and abstract ideas” are not patentable. E.g., Alice Corp. v. CLS Bank Int’l, 573 U.S. 208, 216 (2014). In determining whether a claim falls within an excluded category, we are guided by the Court’s two-part framework, described in Mayo and Alice. Id. at 217–18 (citing Mayo Collaborative Servs. v. Prometheus Labs., Inc., 566 U.S. 66, 75–77 (2012)). In accordance with that framework, we first determine what concept the claim is “directed to.” See Alice, 573 U.S. at 219 (“On their face, the claims before us are drawn to the concept of intermediated settlement, i.e., the use of a third party to mitigate settlement risk.”); see also Bilski v. Kappos, 561 U.S. 593, 611 (2010) (“Claims 1 and 4 in petitioners’ application explain the basic concept of hedging, or protecting against risk.”). Concepts determined to be abstract ideas, and thus patent ineligible, include certain methods of organizing human activity, such as fundamental economic practices (Alice, 573 U.S. at 219–20; Bilski, 561 U.S. at 611); mathematical formulas (Parker v. Flook, 437 U.S. 584, 594–95 (1978)); and mental processes (Gottschalk v. Benson, 409 U.S. 63, 67 (1972)). Concepts determined to be patent eligible include physical and chemical processes, such as “molding rubber products” (Diamond v. Diehr, 450 U.S. 175, 191 (1981)); “tanning, dyeing, making water-proof cloth, vulcanizing India Appeal 2019-006006 Application 14/419,010 8 rubber, smelting ores” (id. at 182 n.7 (quoting Corning v. Burden, 56 U.S. 252, 267–68 (1854))); and manufacturing flour (Benson, 409 U.S. at 69 (citing Cochrane v. Deener, 94 U.S. 780, 785 (1876))). In Diehr, the claim at issue recited a mathematical formula, but the Court held that “a claim drawn to subject matter otherwise statutory does not become nonstatutory simply because it uses a mathematical formula.” Diehr, 450 U.S. at 187; see also id. at 191 (“We view respondents’ claims as nothing more than a process for molding rubber products and not as an attempt to patent a mathematical formula.”). Having said that, the Court also indicated that a claim “seeking patent protection for that formula in the abstract . . . is not accorded the protection of our patent laws, and this principle cannot be circumvented by attempting to limit the use of the formula to a particular technological environment.” Id. (citation omitted) (citing Benson and Flook); see, e.g., id. at 187 (“It is now commonplace that an application of a law of nature or mathematical formula to a known structure or process may well be deserving of patent protection.”). If the claim is “directed to” an abstract idea, we turn to the second step of the Alice and Mayo framework, where “we must examine the elements of the claim to determine whether it contains an ‘inventive concept’ sufficient to ‘transform’ the claimed abstract idea into a patent- eligible application.” Alice, 573 U.S. at 221 (internal quotation marks omitted). “A claim that recites an abstract idea must include ‘additional features’ to ensure ‘that the [claim] is more than a drafting effort designed to monopolize the [abstract idea].’” Id. (alterations in original) (quoting Mayo, 566 U.S. at 77). “[M]erely requir[ing] generic computer implementation[] fail[s] to transform that abstract idea into a patent-eligible invention.” Id. Appeal 2019-006006 Application 14/419,010 9 B. USPTO Section 101 Guidance In January 2019, the U.S. Patent and Trademark Office (USPTO) published revised guidance on the application of § 101. See 2019 Revised Patent Subject Matter Eligibility Guidance, 84 Fed. Reg. 50 (Jan. 7, 2019) (“Revised Guidance”).2 “All USPTO personnel are, as a matter of internal agency management, expected to follow the guidance.” Id. at 51; see also October 2019 Update at 1. Under the Revised Guidance and the October 2019 Update, we first look to whether the claim recites: (1) any judicial exceptions, including certain groupings of abstract ideas (i.e., mathematical concepts, certain methods of organizing human activity such as a fundamental economic practice, or mental processes) (“Step 2A, Prong One”); and (2) additional elements that integrate the judicial exception into a practical application (see MPEP §§ 2106.05(a)–(c), (e)–(h) (9th ed. Rev. 08.2017, Jan. 2018)) (“Step 2A, Prong Two”).3 Revised Guidance, 84 Fed. Reg. at 52–55. 2 In response to received public comments, the Office issued further guidance on October 17, 2019, clarifying the Revised Guidance. USPTO, October 2019 Update: Subject Matter Eligibility (the “October 2019 Update”) (available at https://www.uspto.gov/sites/default/files/ documents/peg_oct_2019_update.pdf). 3 This evaluation is performed by (a) identifying whether there are any additional elements recited in the claim beyond the judicial exception, and (b) evaluating those additional elements individually and in combination to determine whether the claim as a whole integrates the exception into a practical application. See Revised Guidance - Section III(A)(2), 84 Fed. Reg. 54–55. Appeal 2019-006006 Application 14/419,010 10 Only if a claim (1) recites a judicial exception and (2) does not integrate that exception into a practical application, do we then look, under Step 2B, to whether the claim: (3) adds a specific limitation beyond the judicial exception that is not “well-understood, routine, conventional” in the field (see MPEP § 2106.05(d)); or (4) simply appends well-understood, routine, conventional activities previously known to the industry, specified at a high level of generality, to the judicial exception. Revised Guidance, 84 Fed. Reg. at 52–56. Revised Guidance Step 2A, Prong 1 Following the Revised Guidance, we first consider whether the claims recite a judicial exception. The Revised Guidance identifies three groupings of subject matter included in the abstract idea exception, including “[m]ental processes—concepts performed in the human mind (including an observation, evaluation, judgment, opinion).” 84 Fed. Reg. at 52. “If a claim, under its broadest reasonable interpretation, covers performance in the mind but for the recitation of generic computer components, then it is still in the mental processes category unless the claim cannot practically be performed in the mind.” Id. at 52, n.14. Claim 1 recites “comparing [a] sample spectrum to the reference spectra in [a] library and compiling a similarity score list of the reference spectra that are most similar to the sample spectrum based on a known similarity indicator,” “determining, with the aid of the exclusion list, the taxonomical relationship between two microbes, whose reference spectra are present in the score list and which belong to different species,” and Appeal 2019-006006 Application 14/419,010 11 “identifying the microbe sample as a microbe mixture if the determined taxonomical relationship is below a specified degree.” Similarly, claim 2 recites “comparing [a] sample spectrum to the reference spectra and compiling a similarity score list of reference spectra that are most similar to the sample spectrum based on a known similarity indicator,” “comparing two reference spectra of the score list whose microbes belong to different species to determine a degree of similarity between said two reference spectra,” and “identifying the microbe sample as a microbe mixture if the similarity of said two compared reference spectra is below a predetermined similarity threshold.” Thus, both claim 1 and claim 2 recite comparing spectra, evaluating similarity, and identifying a sample as a mixture if certain criteria are met. Claim 1 also recites consulting an exclusion list to determine the taxonomical relationship between two microbes. All of these steps consist of observation and evaluation, which can practically be performed in the human mind. Claims 1 and 2 therefore recite a mental process, which is an abstract idea and a judicial exception to patentability. Revised Guidance Step 2A, Prong 2 Although claims 1 and 2 recite an abstract idea, they would still be patent-eligible if “the claim as a whole integrates the recited judicial exception into a practical application of the exception.” Revised Guidance, 84 Fed. Reg. at 54. “A claim that integrates a judicial exception into a practical application will apply, rely on, or use the judicial exception in a manner that imposes a meaningful limit on the judicial exception.” Id. The analysis of whether a claim integrates a judicial exception into a practical Appeal 2019-006006 Application 14/419,010 12 application includes “[i]dentifying whether there are any additional elements recited in the claim beyond the judicial exception(s)” and “evaluating those additional elements individually and in combination to determine whether they integrate the exception into a practical application.” Id. at 54–55. The exemplary considerations indicating that an additional element may integrate an exception into a practical application include “[a]n additional element [that] reflects an improvement in the functioning of a computer, or an improvement to other technology or technical field.” Id. at 55. However, “an additional element [that] adds insignificant extra-solution activity to the judicial exception” is an indication that “a judicial exception has not been integrated into a practical application.” Id. Such insignificant extra-solution activity includes “mere data gathering such as a step of obtaining information about credit card transactions so that the information can be analyzed in order to detect whether the transactions were fraudulent.” Id. at 55, n.31. Here, in addition to the steps that are equivalent to mental processes, claim 1 recites “providing a library of reference spectra of microbes and an exclusion list indicative of a degree of taxonomical relationship between the microbes of the reference spectra” and “acquiring a sample spectrum of the microbe sample.” Claim 2 similarly recites “providing a library of reference spectra of microbes” and “acquiring a sample spectrum of the microbe sample.” “[P]roviding a library of reference spectra of microbes,” with or without an exclusion list, and “acquiring a sample spectrum,” however, are steps required to gather the data for the mental processes of “comparing the sample spectrum to the reference spectra in the library and compiling a Appeal 2019-006006 Application 14/419,010 13 similarity score list,” and (for claim 1) “determining, with the aid of the exclusion list, the taxonomical relationship between two microbes” of different species with reference spectra present in the score list or (for claim 2) “comparing two reference spectra of the score list whose microbes belong to different species to determine a degree of similarity between said two reference spectra,” in order to “identify[] the microbe sample as a microbe mixture” if the taxonomical relationship is below a specified degree (claim 1) or the similarity of the reference spectra is below a predetermined threshold (claim 2). The “providing” and “acquiring” data-gathering steps are therefore merely insignificant extra-solution activity, and are not an indication that the recited judicial exception has been integrated into a practical application. Claims 1 and 2 also recite “when a microbe mixture has been identified, performing a mixture analysis using combination spectra.” This contingent limitation, however, also fails to meaningfully limit the recited abstract idea and therefore does not integrate the judicial exception into a practical application. The limitation is recited at a high level of generality, and reads on any method of carrying out “mixture analysis using combination spectra.” In essence, it amounts to a requirement to apply the outcome of the mental processes recited in the claims: if thinking about the data as recited indicates that the sample is a microbe mixture, carry out a mixture analysis. “Stating an abstract idea while adding the words apply it is not enough for patent eligibility.” Alice, 573 U.S. at 223 (internal quotation marks omitted). The final limitation of claims 1 and 2 is therefore insignificant post-solution activity. Appeal 2019-006006 Application 14/419,010 14 Considering the claims as a whole confirms that they are directed to a judicial exception, because the claim limitations amount to directions to gather certain data, think about it a certain way, and apply (if appropriate) the outcome of that thought process. We therefore conclude that claims 1 and 2 do not integrate the recited judicial exception into a practical application. Revised Guidance Step 2B The Revised Guidance directs us to consider whether claims 1 and 2 include “additional elements . . . [that] provide[] ‘significantly more’ than the recited judicial exception.” 84 Fed. Reg. at 56. The Revised Guidance states that an additional element that “simply appends well-understood, routine, conventional activities previously known to the industry, specified at a high level of generality, to the judicial exception, . . . is indicative that an inventive concept may not be present.” Id. As discussed above, and aside from the elements that are directed to mental processes, claims 1 and 2 recite providing a library of reference spectra, acquiring a sample spectrum, and (conditionally) performing mixture analysis. These steps, however, are recited at a high level of generality; no specific process is recited, for example, for acquiring a sample spectrum or for performing a mixture analysis using combination spectra. Moreover, Appellant’s Specification states that “mass-spectrometric detection of specific molecular cell components of microorganisms” has been “known for some years.” Spec. ¶ 6. “[I]dentification is achieved by means of a similarity analysis between a mass spectrum of the bacteria to be identified and reference mass spectra (simply called reference spectra in the following) Appeal 2019-006006 Application 14/419,010 15 of known bacteria.” Id. ¶ 8. “The reference spectra are generally collated in one or more collections, for which the term ‘library’ is used in the following. A library thus comprises one or more collections of reference spectra.” Id. ¶ 9. The Specification thus demonstrates that providing a library of reference spectra is well-known, routine, and conventional. The Specification also states that “[t]he identification of bacteria by mass-spectrometric measurements has been described in [the prior art]. . . . The identification is achieved by means of a similarity analysis between a mass spectrum of the bacteria to be identified and reference mass spectra . . . of known bacteria.” Id. ¶ 8 (emphasis added). The Specification thus shows that acquiring a sample spectrum, as recited in claims 1 and 2, was also well- known, routine, and conventional. In addition, the Specification states that [i]f a mixture is suspected, methods for the identification of microbes in mixtures can be used, as described in the documents DE 10 2009 007 266 A1 (M. Kostrzewa et al., corresponding to GB 2 467 636 A or US-2010-0248298-A1). These documents are included here by reference. The documents describe a method for the identification of microbe species in mixtures which is designated below as “mixture analysis by combination spectra”. Id. ¶ 25. This description again confirms that mixture analysis using combination spectra is known in the art and used routinely when a mixture of microbes in a sample is suspected. In addition to the above limitations, claim 1 also requires providing an exclusion list indicative of a degree of taxonomical relationship. The Specification states that “an experienced specialist determine[s] the relationships between the microbes of all the reference spectra in the library once, and add[s] to the library a matrix-like relationship list with the microbe Appeal 2019-006006 Application 14/419,010 16 species names used for the reference spectra. This list is called an ‘exclusion list.’” Spec. ¶ 32. “With the aid of this list, the computer program for the evaluation of the mass spectra can then determine whether such a near relationship exists, and negate the presence of a mixture when this is the case.” Id. That is, a person reviews the microbes in the library and identifies those microbes that are so closely related that their appearance together in a score list of reference spectra that are similar to a sample’s spectrum is not due to both of the reference microbes being present in the sample but only because those microbes are closely related, and so their reference spectra are similar to each other. The Specification makes clear, however, that this process—carried out by a person—is routine and conventional. See Spec. ¶ 21: [I]t has become established practice to create a tabular score list with the names of the microbe strains whose reference spectra resulted in the best similarity scores. . . . This score list should then be assessed by a specialist, using his/her experience to make the definitive identification. The specialist must in particular assess whether the sample is a mixture of different microbe species when several microbe species are listed in the score list. In summary, the combination of elements recited in claims 1 and 2 does not amount to significantly more than the judicial exceptions themselves, and under 35 U.S.C. § 101 the claimed method is not eligible for patenting. Appellant’s Arguments Appellant argues that the Examiner has not clearly identified the abstract idea recited in the claims, and the claim limitations that relate to the Appeal 2019-006006 Application 14/419,010 17 abstract idea. Appeal Br. 5. Appellant argues that “[g]eneralized statements like those [in the Final Action] do not permit the applicant to properly understand the basis of the rejection.” Id. at 6. See also Reply Br. 3 (“[T]here was no identification of specific limitations considered to be an abstract idea, making it impossible for the appellant to formulate an appropriate response to the rejection.”). We do not agree with Appellant’s position. The “PTO carries its procedural burden of establishing a prima facie case when its rejection satisfies 35 U.S.C. § 132, in ‘notify[ing] the applicant . . . [by] stating the reasons for [its] rejection, or objection or requirement, together with such information and references as may be useful in judging of the propriety of continuing the prosecution of [the] application.’ 35 U.S.C. § 132.” In re Jung, 637 F.3d 1356, 1362 (Fed. Cir. 2011) (alterations in original). Here, the Examiner stated that “the claimed invention only involves the abstract consideration of data, per se.” Ans. 4. While the Examiner did not use the phrase “mental processes,” the phrase “consideration of data” is reasonably interpreted to mean the same thing. In our view, the Examiner explained the basis of the rejection adequately to allow Appellant to recognize and respond to the rejection. See Jung, 637 F.3d at 1362 (Section 132 “‘is violated when a rejection is so uninformative that it prevents the applicant from recognizing and seeking to counter the grounds for rejection.’ Chester v. Miller, 906 F.2d 1574, 1578 (Fed. Cir. 1990).”). Appellant also argues that the claims provide an improvement in the mass-spectrometric identification of microbes; specifically, in “the determination of whether or not to employ a mixture analysis using combination spectra.” Appeal Br. 7. Appellant argues that the claimed Appeal 2019-006006 Application 14/419,010 18 method “uses the degree of taxonomical relationship between microbes of different species in a score list as a means for determining quickly whether . . . a mixture analysis would likely be advantageous.” Id. at 8. Appellant argues that the claimed method “provides a more accurate method of identifying when a sample contains a mix of microbe species so that a decision may be made as to whether a ‘mixture analysis using combination spectra’ should be employed.” Id. Appellant also argues that [d]etermining whether the sample contains a mixture of species greatly simplifies and accelerates the identification process by eliminating the need for undertaking unnecessary identification steps. This step of identifying a microbe mixture thus clearly improves the technology of microbe identification, and indicates that any judicial exception is integrated into a practical application. Reply Br. 7. These arguments are unpersuasive. The Specification describes the conventional method for “[t]he identification of bacteria by mass- spectrometric measurements,” in which “[t]he identification is achieved by means of a similarity analysis between a mass spectrum of the bacteria to be identified and reference mass spectra.” Spec. ¶ 8. “The similarities between two mass spectra are usually characterized by a ‘similarity indicator.’” Id. ¶ 16. “[I]t has become established practice to create a tabular score list with the names of the microbe strains whose reference spectra resulted in the best similarity scores.” Id. ¶ 21. “This score list should then be assessed by a specialist, using his/her experience to make the definitive identification. The specialist must in particular assess whether the sample is a mixture of Appeal 2019-006006 Application 14/419,010 19 different microbe species when several microbe species are listed in the score list.” Id. “Since the mass-spectrometric identification method is nowadays used in hundreds of routine laboratories, the requirement to have a specialist assessment is no longer appropriate. . . . The assessment of the score list therefore has to be largely transferred to a computer program.” Id. ¶ 22. Thus, the Specification makes clear that the claimed methods amount to using a computer to carry out the same analysis of the similar spectra in a score list that is conventionally carried out by a human specialist who mentally assesses the same data. “An additional element . . . [that] merely includes instructions to implement an abstract idea on a computer, or merely uses a computer as a tool to perform an abstract idea,” is not an improvement to a technical field and is an indication that “a judicial exception has not been integrated into a practical application.” Revised Guidance, 84 Fed. Reg. at 55. Appellant also argues that “the invention is limited to use of a mass spectrometer, so any judicial exception is clearly implemented with a particular machine that is integral to the claim.” Reply Br. 7. This argument is also unpersuasive, because, at most, claims 1 and 2 both require using a mass spectrometer only to “acquir[e] a sample spectrum of [a] microbe sample.” Thus, the machine that Appellant points to is used only to gather data for use in the claimed method, but “[u]se of a machine that contributes only nominally or insignificantly to the execution of the claimed method (e.g., in a data gathering step or in a field-of-use limitation) would not integrate a judicial exception or provide significantly more.” MPEP § 2106.05(b) (citing CyberSource v. Retail Decisions, Inc., 654 F.3d 1366, Appeal 2019-006006 Application 14/419,010 20 1370 (Fed. Cir. 2011) (“We have held that mere ‘[data-gathering] step[s] cannot make an otherwise nonstatutory claim statutory.’”) (alterations in original)). Appellant also argues that, in McRO, Inc. v. Bandai Namco Games Amer., Inc., 837 F.3d 1299 (Fed. Cir. 2016), the “court recognized that the claims in question were not ‘abstract ideas’ since they used limited rules in a process specifically designed to achieve an improved technological result in conventional industry practice.” Appeal Br. 12. Appellant argues that “[t]he same analysis applies equally to the claims of the present invention, which also use limited rules to achieve an improved technological result in a specific field.” Id. This argument is also unpersuasive. The invention in McRO “improv[ed] the prior art through ‘the use of rules, rather than artists, to set the morph weights and transitions between phonemes’” in such a way as to “produce ‘accurate and realistic lip synchronization and facial expressions in animated characters.’” McRO, 837 F.3d at 1313. “The rules are limiting in that they define morph weight sets as a function of the timing of phoneme sub-sequences.” Id. Appellant’s claims recite no rules with similar specificity to those in McRO. Rather, claim 1 merely requires “determining, with the aid of the exclusion list, the taxonomical relationship between two microbes, whose reference spectra are present in the score list and which belong to different species,” and “identifying the microbe sample as a microbe mixture if the determined taxonomical relationship is below a specified degree.” Claim 1 does not recite any “limited rules,” Appeal Br. 12, regarding how the exclusion list is used to aid in determining the taxonomical relationship Appeal 2019-006006 Application 14/419,010 21 between species or what degree of taxonomical relationship is critical to determining that a sample contains a mixture of microbes. Claim 2 is even less specific, and merely requires “comparing two reference spectra of the score list whose microbes belong to different species to determine a degree of similarity between said two reference spectra” and “identifying the microbe sample as a microbe mixture if the similarity of said two compared reference spectra is below a predetermined similarity threshold.” Again, the claim does not recite any rules regarding how the reference spectra are compared to determine a degree of similarity, nor does it identify what similarity threshold is critical to determining that a sample contains a mixture of microbes. Thus, we do not agree that McRO supports patent-eligibility of the instant claims. For all of the reasons discussed above, we affirm the rejection of claims 1 and 2 under 35 U.S.C. § 101. Claims 6–8 and 10–13 fall with claims 1 and 2 because they were not argued separately. 37 C.F.R. § 41.37(c)(1)(iv). DECISION SUMMARY In summary: Claims Rejected 35 U.S.C. § Reference(s)/Basis Affirmed Reversed 1, 2, 6–8, 10–13 101 Eligibility 1, 2, 6–8, 10–13 Appeal 2019-006006 Application 14/419,010 22 TIME PERIOD FOR RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(1)(iv). AFFIRMED Copy with citationCopy as parenthetical citation